Cargando…

Risk of Uveitis in Patients With Inflammatory Bowel Disease on Immunosuppressive Drug Therapy

BACKGROUND: Inflammatory bowel disease (IBD) patients may develop anterior uveitis. METHODS: An observational cohort of IBD patients followed new users of (1) tumor necrosis factor inhibitor versus nonbiologic agents or (2) adalimumab versus infliximab until occurrence of anterior uveitis or treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barberio, Julie, Kim, Seoyoung C, Roh, Miin, Lewis, James D, Desai, Rishi J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802084/ https://www.ncbi.nlm.nih.gov/pubmed/36776495 http://dx.doi.org/10.1093/crocol/otaa041

Ejemplares similares

Economic Burden of Fatigue in Inflammatory Bowel Disease
por: Ananthakrishnan, Ashwin N, et al.
Publicado: (2023)

Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study
por: Crepaldi, Martina, et al.
Publicado: (2023)

The Use of Acute Immunosuppressive Therapy to Improve Antibiotic Efficacy against Intracellular Staphylococcus aureus
por: Beam, Jenna E., et al.
Publicado: (2022)

Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection
por: Long, Millie D, et al.
Publicado: (2022)

Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery
por: Lee, Dong-won, et al.
Publicado: (2017)

Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease
por: Rai, Victoria, et al.
Publicado: (2021)

New Immunosuppressive Therapies in Uveitis Treatment
por: Mérida, Salvador, et al.
Publicado: (2015)

An Autoimmune Protocol Diet Improves Patient-Reported Quality of Life in Inflammatory Bowel Disease
por: Chandrasekaran, Anita, et al.
Publicado: (2019)

Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10(−/−) Mice
por: Mannion, Anthony, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

Fecal Incontinence in Inflammatory Bowel Disease
por: Kamal, Natasha, et al.
Publicado: (2021)

Systemic immunosuppressive therapies for uveitis in developing countries
por: Agrawal, Hitesh, et al.
Publicado: (2020)

Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
por: Jain, Avni, et al.
Publicado: (2019)

Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel Disease
por: Jonason, David E, et al.
Publicado: (2020)

SARS-CoV-2 in inflammatory bowel disease population: Antibodies, disease and correlation with therapy
por: Conti, Clara Benedetta, et al.
Publicado: (2022)

Association Between Inflammatory Bowel Disease and Pruritus
por: Iwamoto, Shiho, et al.
Publicado: (2020)

Opioid Use in Patients With Inflammatory Bowel Disease
por: Lin, Xiwu, et al.
Publicado: (2020)

Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort
por: Rifkin, Andrew S, et al.
Publicado: (2023)

Vaccination Rates and Family Barriers Among Children with Inflammatory Bowel Disease
por: Holland, Kathleen J, et al.
Publicado: (2020)

Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease
por: Gong, Shan-Shan, et al.
Publicado: (2019)

Using Patient Completed Screening Tools to Predict Risk of Malnutrition in Patients With Inflammatory Bowel Disease
por: Taylor, Lorian M, et al.
Publicado: (2021)

Is Occupation a Risk Factor for Developing Inflammatory Bowel Disease? A Case–Control Study
por: Mauriz-Barreiro, Violeta, et al.
Publicado: (2023)

Patients’ Willingness and Perspectives Toward Chimeric Antigen Receptor T-Regulatory Cell Therapy for Inflammatory Bowel Diseases
por: Vent-Schmidt, Jens, et al.
Publicado: (2020)

The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010–2020
por: Wewer, Mads Damsgaard, et al.
Publicado: (2022)

Fatigue in patients with inflammatory bowel disease in Eastern China
por: Gong, Shan-Shan, et al.
Publicado: (2021)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Hospitalizations and in-hospital mortality for inflammatory bowel disease in Brazil
por: Guedes, Ana Luiza Vilar, et al.
Publicado: (2022)

Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease
por: Wiles, C Alex, et al.
Publicado: (2021)

Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study
por: Desai, Rishi J, et al.
Publicado: (2017)

Overuse of Tuberculosis Surveillance Testing in Patients With Inflammatory Bowel Disease Compared to Non-IBD Patients on Biologic Therapy
por: Fine, Sean, et al.
Publicado: (2021)

Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients
por: Benson, Melissa J, et al.
Publicado: (2020)

Comparative study between bowel ultrasound and magnetic resonance enterography among Egyptian inflammatory bowel disease patients
por: Kamel, Shimaa, et al.
Publicado: (2020)

HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018)

Disease impact on the quality of life of children with inflammatory bowel disease
por: Chouliaras, Giorgos, et al.
Publicado: (2017)

The Impact of Inflammatory Bowel Disease Clinic On-site Vaccination Services
por: Hussain, Nadeen, et al.
Publicado: (2021)

Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand
por: Aluzaite, Kristina, et al.
Publicado: (2021)

Prevalence and Factors Associated With Fecal Urgency Among Patients With Ulcerative Colitis and Crohn’s Disease in the Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease
por: Dawwas, Ghadeer K, et al.
Publicado: (2021)

Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis
por: Mahlich, Joerg, et al.
Publicado: (2021)

Nurse-Provided Medication Guidance for Improving Drug Adherence to Thiopurines in Outpatients With Inflammatory Bowel Disease: A Single-Center Prospective Study
por: Shinzaki, Shinichiro, et al.
Publicado: (2021)

Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort
por: Lee, Way Seah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0hujaqhjdgvfqnbda8mudnbdfc